2014
DOI: 10.1002/ejhf.68
|View full text |Cite
|
Sign up to set email alerts
|

EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM

Abstract: Background The EURObservational Research Programme is a rolling programme of cardiovascular registries and surveys of the European Society of Cardiology (ESC). These registries will provide information on the nature of cardiovascular disease and its management. This manuscript provides an update on new literature on peripartum cardiomyopathy (PPCM), published since the 2010 Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on PPCM, and describes a new reg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
197
2
15

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 168 publications
(220 citation statements)
references
References 47 publications
6
197
2
15
Order By: Relevance
“…Larger clinical data sets are collected and analysed, thus allowing more insight into the pathophysiology of the disease and providing important information for diagnosis and management of these patients. Large clinical registries on peripartum heart failure (ESC EUROOBS program (www.escardio.org) [40] together with experimental research are needed to further broaden our understanding of PPCM with regard to its aetiology, risk factors, diagnosis and, most importantly, optimised treatment strategies and management.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Larger clinical data sets are collected and analysed, thus allowing more insight into the pathophysiology of the disease and providing important information for diagnosis and management of these patients. Large clinical registries on peripartum heart failure (ESC EUROOBS program (www.escardio.org) [40] together with experimental research are needed to further broaden our understanding of PPCM with regard to its aetiology, risk factors, diagnosis and, most importantly, optimised treatment strategies and management.…”
Section: Resultsmentioning
confidence: 99%
“…In fact, the rising interest in pregnancy-related cardiac research [13,25,26], the international registry on PPCM as part of the EURObservational Research Programme (http://www. eorp.org) [27] and other national and international reporting facilities [12,28,29] may contribute to greater awareness and the larger number of PPCM cases diagnosed in recent years.…”
Section: Peripartum Cardiomyopathy (Ppcm)mentioning
confidence: 99%
“…Среди фармакологических препаратов, используемых при лечении собственно СН у пациенток с ПКМП, используются диуретики, вазодилататоры, инотроп-ные средства, ингибиторы ангиотензин превращаю-щего фермента (ИАПФ), β-адреноблокаторы (β-АБ), антикоагулянты, антиаритмические препараты [58]. Имеется опыт применения перспективных, однако до конца не изученных фармакологических средств, влияющих на патогенетические механизмы ПКМП.…”
Section: общие принципы леченияunclassified
“…Если возникает необходимость, обычно используют допамин, добутамин, милринон или сердечные глико-зиды (СГ) [53,58]. Ранее сообщалось, что левосимен-дан у больных ПКМП снижает давление заклинива-ния в легочных капиллярах и увеличивает сердечный выброс [11], однако в рандомизированном исследова-нии при его назначении 24 больным (0,1 мкг/кг/мин.…”
Section: инотропные препаратыunclassified
See 1 more Smart Citation